© 2015 Korean Breast Cancer Society. All rights reserved. http://ejbc.kr | pISSN 1738-6756 eISSN 2092-9900
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
All authors would like to withdraw the article because they have found a mistake in selecting subjects for this study.
Some patients underwent neoadjuvant chemotherapy following sentinel lymph node biopsy were selected inadvertently as the study subjects, despite those who underwent neoadjuvant chemotherapy should be excluded from this study, and most of them were also considered as the sentinel lymph node failure group because these patients underwent axillary dissection regardless of the results of sentinel lymph node biopsy.
Although a reanalysis of corrected data still demonstrated higher failure rate of sentinel lymph node biopsy in the patients with axillary arch than in the patients without axillary arch (4.2% vs. 1.2%), the difference of sentinel lymph node biopsy failure rate between two groups became statistically not significant (p=0.076) and as a result, the original conclusions have been compromised.
We deeply regret the mistake to review the patient’s medical records carelessly.
The following authors agreed with this retraction decision: Won Ho Kil, Jeong Eon Lee, Seok Jin Nam.
This article was retracted on March 31, 2015
The online version of the original article can be found at http://dx.doi.org/10.4048/jbc.2014.17.3.244
Retraction note to:
“Clinical Significance of the Axillary Arch in Sentinel Lymph Node Biopsy”
by Won Ho Kil, Jeong Eon Lee, Seok Jin Nam (Journal of Breast Cancer 2014;17(3):244-9)
RETRACTION
J Breast Cancer 2015 March; 18(1): 101-101 http://dx.doi.org/10.4048/jbc.2015.18.1.101
